Literature DB >> 17303426

Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002.

Miranda F Ernst1, Lonneke V van de Poll-Franse, Jan A Roukema, Jan Willem W Coebergh, Cornelia M J van Gestel, Gerard Vreugdenhil, Marieke J Louwman, Adri C Voogd.   

Abstract

We performed a population-based study, including 1089 patients with primary metastatic breast cancer, diagnosed in South-East Netherlands between 1975 and 2002, and tried to give an answer to the question if prognosis of this patient group has improved or not. Follow-up was completed until 1 January 2005. The median survival times for patients with primary metastatic disease were 18, 17 and 20.5 months for patients diagnosed in the periods 1975-1984, 1985-1994 and 1995-2002, respectively. A multivariate analysis, including age, tumour size and information on the localization of metastatic disease and the number of metastatic sites, showed that patients diagnosed in the period 1995-2002 had a 18% lower death risk (95% confidence interval 5-30) compared to those diagnosed in the period 1985-1994. These data show that the prognosis of patients with primary metastatic breast cancer remained unchanged between 1975 and 1994 and that some progress has been made after 1994.

Entities:  

Mesh:

Year:  2007        PMID: 17303426     DOI: 10.1016/j.breast.2007.01.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  18 in total

1.  Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.

Authors:  Daniel E Abbott; Antoine Brouquet; Elizabeth A Mittendorf; Andreas Andreou; Funda Meric-Bernstam; Vicente Valero; Marjorie C Green; Henry M Kuerer; Steven A Curley; Eddie K Abdalla; Kelly K Hunt; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2012-01-29       Impact factor: 3.982

2.  Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology.

Authors:  Ummugul Uyeturk; Berna Oksuzoglu; Tulay Akman; Ibrahim Turker; Nur Sener; Didem Tastekin; Oznur Bal; Veli Berk; Ulku Yalcintas Arslan; Zuhat Urakci; Cemil Bilir; Ugur Yilmaz; Dogan Yazilitas; Arife Ulas; Ozlem Uysal Sonmez; Burcin Budakoglu; Sener Cihan; Mukremin Uysal
Journal:  Med Oncol       Date:  2014-03-22       Impact factor: 3.064

Review 3.  Prognostic factors and survival in metastatic breast cancer: A single institution experience.

Authors:  Afef Khanfir; Faiez Lahiani; Racem Bouzguenda; Ines Ayedi; Jamel Daoud; Mounir Frikha
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-14

4.  Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

Authors:  Marilyn L Kwan; Wendy Y Chen; Candyce H Kroenke; Erin K Weltzien; Jeannette M Beasley; Sarah J Nechuta; Elizabeth M Poole; Wei Lu; Michelle D Holmes; Charles P Quesenberry; John P Pierce; Xiao Ou Shu; Bette J Caan
Journal:  Breast Cancer Res Treat       Date:  2011-12-21       Impact factor: 4.872

5.  Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.

Authors:  Marilyn L Kwan; Wendy Y Chen; Shirley W Flatt; Erin K Weltzien; Sarah J Nechuta; Elizabeth M Poole; Michelle D Holmes; Ruth E Patterson; Xiao Ou Shu; John P Pierce; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-13       Impact factor: 4.254

6.  Ovarian metastasis from breast cancer mimicking a primary ovarian neoplasm: A case report.

Authors:  Yoshika Akizawa; Toshiyuki Kanno; Yu Horibe; Yumi Shimizu; Eiichiro Noguchi; Tomoko Yamamoto; Takahiro Okamoto; Yoji Nagashima; Tsutomu Tabata
Journal:  Mol Clin Oncol       Date:  2021-05-17

7.  Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion.

Authors:  Jessica D Sims; Jessica McCready; Daniel G Jay
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

8.  SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation.

Authors:  Jetske Ruiterkamp; Adri C Voogd; Vivianne C G Tjan-Heijnen; Koop Bosscha; Yvette M van der Linden; Emiel J Th Rutgers; Epie Boven; Maurice J C van der Sangen; Miranda F Ernst
Journal:  BMC Surg       Date:  2012-04-02       Impact factor: 2.102

Review 9.  Breast surgery for metastatic breast cancer.

Authors:  Giuliano Tosello; Maria Regina Torloni; Bruna S Mota; Teresa Neeman; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival.

Authors:  S Ciatto; N Houssami; F Martinelli; R Bonardi; F H Cafferty; S W Duffy
Journal:  Br J Cancer       Date:  2008-07-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.